3-nitro-N-(8-quinolinyl)benzamide

3-nitro-N-(8-quinolinyl)benzamide Suppliers list
Company Name: ATK CHEMICAL COMPANY LIMITED
Tel: +undefined-21-51877795
Email: ivan@atkchemical.com
Products Intro: Product Name:3-nitro-N-(8-quinolinyl)benzamide
CAS:62802-77-1
Purity:98% Package:10MG;50MG;100MG,1G,5G,10G.100G
Company Name: TargetMol Chemicals Inc.
Tel: +1-781-999-5354 +1-00000000000
Email: marketing@targetmol.com
Products Intro: Product Name:VEGFR-2-IN-29
CAS:62802-77-1
Purity:99.84% Package:5mg;48USD|10mg;83USD|25mg;173USD
Company Name: TargetMol Chemicals Inc.
Tel:
Email: support@targetmol.com
Products Intro: Product Name:WAY-302159
CAS:62802-77-1
Package:1 mg;10 mg;100 mg;200 mg;25 mg;5 mg;50 mg Remarks:REAGENT;FOR LABORATORY USE ONLY
Company Name: Aladdin Scientific
Tel:
Email: tp@aladdinsci.com
Products Intro: Product Name:3-nitro-N-(quinolin-8-yl)benzamide
CAS:62802-77-1
Purity:98% Package:$344.9/5mg;$618.9/10mg;$1202.9/25mg;$1923.9/50mg;$3090.9/100mg;Bulk package Remarks:98%
Company Name: Shanghai YuanYe Biotechnology Co., Ltd.  
Tel: 021-61312847; 18021002903
Email: 3008007409@qq.com
Products Intro: Product Name:VEGFR-2-IN-29
CAS:62802-77-1
Purity:98% Package:25mg Remarks:S23473

3-nitro-N-(8-quinolinyl)benzamide manufacturers

  • VEGFR-2-IN-29
  • VEGFR-2-IN-29 pictures
  • $34.00 / 1mg
  • 2024-11-19
  • CAS:62802-77-1
  • Min. Order:
  • Purity: 99.84%
  • Supply Ability: 10g
3-nitro-N-(8-quinolinyl)benzamide Basic information
Product Name:3-nitro-N-(8-quinolinyl)benzamide
Synonyms:3-nitro-N-(8-quinolinyl)benzamide;WAY-302159;3-Nitro-N-(quinolin-8-yl)benzamide;Inhibitor,VEGFR,quinoline amide,inhibit,WAY 302159,HUVEC,Vascular endothelial growth factor receptor,WAY302159;VEGFR-2-IN-29
CAS:62802-77-1
MF:C16H11N3O3
MW:293.27684
EINECS:
Product Categories:
Mol File:62802-77-1.mol
3-nitro-N-(8-quinolinyl)benzamide Structure
3-nitro-N-(8-quinolinyl)benzamide Chemical Properties
storage temp. Store at -20°C
solubility DMSO : 20 mg/mL (68.19 mM; ultrasonic and warming and heat to 60°C)
form Solid
color Light brown to brown
Safety Information
MSDS Information
3-nitro-N-(8-quinolinyl)benzamide Usage And Synthesis
UsesVEGFR-2-IN-29 (Compound 5) is a VEGFR-2 inhibitor with an IC50 of 16.5 nM[1].
IC 50VEGFR-2: 16.5 nM (IC50)
References[1] Yang Y, et al. Design, synthesis and biological evaluation of quinoline amide derivatives as novel VEGFR-2 inhibitors. Bioorg Med Chem Lett. 2010 Nov 15;20(22):6653-6. DOI:10.1016/j.bmcl.2010.09.014
3-nitro-N-(8-quinolinyl)benzamide Preparation Products And Raw materials
Tag:3-nitro-N-(8-quinolinyl)benzamide(62802-77-1) Related Product Information
2,4-PyriMidinediaMine with linker N-(4-CHLOROPHENYL)-2-[(PYRIDIN-4-YLMETHYL)AMINO]BENZAMIDE 3-[5-[2-[(2-Methoxyethyl)methylamino]ethoxy]-1H-indol-2-yl]-2(1H)-quinolinone 3'-[(5,6,7,8-Tetrahydro[1]benzothieno[2,3-d]pyrimidine-4-yl)oxy]acetophenone Quinazoline, 4-[(4-bromophenyl)methoxy]- 1H-1,2,4-Triazole-3-carboxamide, 1-(3-chloro-4-fluorophenyl)-N-(3,4-dimethoxyphenyl)-5-(3,4,5-trimethoxyphenyl)- VEGFR3/FLT4 Protein, Human, Recombinant (His & Avi) 2-Quinazolinecarboxylic acid, 4-[3-fluoro-4-[[[(3-methylphenyl)amino]carbonyl]amino]phenoxy]-, ethyl ester Pazopanib Impurity 3 Benzoic acid, 4-[[4-[[2-[2,4-dioxo-5-(phenylmethylene)-3-thiazolidinyl]acetyl]amino]benzoyl]amino]-, ethyl ester VEGFR3/FLT4 Protein, Human, Recombinant (aa 25-776, His & Avi), Biotinylated 3-Pyridinecarbonitrile, 2-hydrazinyl-6-(2-naphthalenyl)-4-(4-nitrophenyl)-

  • HomePage | Member Companies | Advertising | Contact us | Previous WebSite | MSDS | CAS Index | CAS DataBase | Privacy | Terms | About Us
  • All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.
    According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.
  • Copyright © 2023 ChemicalBook All rights reserved.